Innovations

Researchers may have found a new biomarker for acute COVID-19

0
smart city and communication network. Smart city dot point connect .internet of things connection metaverse technology.

Researchers at Karolinska Institutet in Sweden have shown that patients with acute COVID-19 infection have increased levels of the cytokine IL-26 in their blood. Moreover, high IL-26 levels correlate with an exaggerated inflammatory response that signifies severe cases of the disease. The findings, which are presented in Frontiers in Immunology, indicate that IL-26 is a potential biomarker for severe COVID-19.  

Inhibitory neuron dysfunction emerges as a modulable mechanism of hyperexcitability

Previous article

Study reveals a mechanism for mitochondrial activation via nucleoid dynamics

Next article

You may also like

Comments

Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations